Supplementary Data from Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
Johannes Brägelmann(University of Cologne), Sven Perner(University Hospital Bonn), Peter Brossart(University of Bonn), Axel S. Merseburger(Universitäres Kinderwunschzentrum Lübeck), Jessica Carlsson(University of Skövde), Mario C. Deng(University of California, Los Angeles), Anne von Mäßenhausen(University Hospital Bonn), Elisabeth Sievers(Karolinska University Hospital), Angela Queisser(University Hospital Bonn), Christine Sanders(Research Center Borstel - Leibniz Lung Center), Stefan Duensing(Heidelberg University), Ignacija Vlašić(Ruđer Bošković Institute), Niklas Klümper(University of Bonn), David Adler(Space Telescope Science Institute), Diana Böhm(Research Center Borstel - Leibniz Lung Center), Jutta Kirfel(Taipei Institute of Pathology), Anne Offermann(University Hospital Münster), Ove Andrén(Örebro University Hospital), Maria A. Svensson(Örebro University), Wenzel Vogel, Isabella Syring(University Hospital Bonn)
Cited by 0
Related Papers
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
|Proceedings of the National Academy of Sciences|2007|1.1k
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration
|Journal of Clinical Oncology|2020|676
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|607
The James Webb Space Telescope Mission
|Publications of the Astronomical Society of the Pacific|2023|477